P4-01-15: Alteration of Y-box Binding Protein-1 Expression Modifies the Response to Endocrine Therapy in Estrogen Receptor Positive Breast Cancer.

2011 ◽  
Author(s):  
T Ito ◽  
S Kamijo ◽  
H Izumi ◽  
K Kohno ◽  
K-I Ito
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Endocrine Therapy ◽  
Binding Protein ◽  
Estrogen Receptor Positive ◽  
Positive Breast Cancer

Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer

2011 ◽  
Vol 133 (1) ◽  
pp. 145-159 ◽  
Author(s):  
Tokiko Ito ◽  
Shinobu Kamijo ◽  
Hiroto Izumi ◽  
Kimitoshi Kohno ◽  
Jun Amano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Endocrine Therapy ◽  
Binding Protein ◽  
Estrogen Receptor Positive ◽  
Positive Breast Cancer

scholarly journals PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

2008 ◽  
Vol 113 (3) ◽  
pp. 509-517 ◽  
Author(s):  
Farrokh Dehdashti ◽  
Joanne E. Mortimer ◽  
Kathryn Trinkaus ◽  
Michael J. Naughton ◽  
Matthew Ellis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Endocrine Therapy ◽  
Predictive Biomarker ◽  
Estrogen Receptor Positive ◽  
Positive Breast Cancer

scholarly journals MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

2010 ◽  
Vol 127 (1) ◽  
pp. 43-51 ◽  
Author(s):  
F. Germán Rodríguez-González ◽  
Anieta M. Sieuwerts ◽  
Marcel Smid ◽  
Maxime P. Look ◽  
Marion E. Meijer-van Gelder ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Endocrine Therapy ◽  
Clinical Benefit ◽  
Independent Predictor ◽  
Expression Level ◽  
Estrogen Receptor Positive ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document